Physician

Jeffrey Lyle Stevens, M.D.

According to 2025 Medicare claims, Jeffrey Stevens, M.D. (NPI: 1114254711) practices ophthalmology in the Boise City, ID market, with the plurality of this provider's patient population coming from Ada, ID. This provider's primary affiliated billing organization is INTERMOUNTAIN EYE AND LASER CENTERS PLLC (NPI: 1730119611; TIN: 820482491) and primary practice location at 83706-1316.

Stevens' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 903 traditional Medicare patients, billed 33,365 HCPCS/CPT codes, and received $2,176,469 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 938 prescription claims across 321 beneficiaries totaling $39,073 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). 2015 DME data shows 13 claims. Open Payments data shows 17 records totaling $467. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $124,446 to $2,176,469. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $59,999 and ending at $39,073. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	710	1,874	$124,446
2016	637	1,825	$113,940
2017	693	2,099	$169,232
2018	606	4,401	$535,062
2019	971	7,389	$950,951
2020	994	5,764	$834,160
2021	638	5,196	$1,071,786
2022	676	6,453	$1,255,940
2023	1,029	25,610	$1,895,611
2024	903	33,365	$2,176,469

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	177	710	$59,999
2016	180	854	$59,437
2017	308	1,025	$55,303
2018	524	2,378	$98,759
2019	453	1,934	$93,536
2020	338	1,227	$66,234
2021	196	628	$30,016
2022	216	674	$36,553
2023	280	797	$48,386
2024	321	938	$39,073

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	13	$678
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	352	1,734	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	396	471	$84
J7999	Compounded drug, not otherwise classified	200	870	$68
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	632	1,154	$64
92134	Imaging of retina	857	2,847	$29

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	189	7,220	$6,262
Moxifloxacin	Moxifloxacin Hcl	127	2,299	$4,102
Latanoprost	Latanoprost	238	14,433	$1,831
Brimonidine Tartrate	Brimonidine Tartrate	72	4,491	$1,381
Ketorolac Tromethamine	Ketorolac Tromethamine	28	1,085	$1,252

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$467	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey Lyle Stevens, M.D.?

Tedicare shows public-source Medicare data for Jeffrey Lyle Stevens, M.D. (NPI 1114254711), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Lyle Stevens, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffrey Lyle Stevens, M.D.?

Jeffrey Lyle Stevens, M.D. is linked to INTERMOUNTAIN EYE AND LASER CENTERS PLLC (billing NPI 1730119611) in the available physician profile data.

Does Jeffrey Lyle Stevens, M.D. have Open Payments data?

Jeffrey Lyle Stevens, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.